Chromium deficiency (Q39944): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Deficiência em humanos é apenas descrita em pacientes recebendo nutrição parenteral total (NPT) prolongada insuficiente em cromo. Hiperglicemia ou tolerância alterada a glicose podem ocorrer. Elevadas concentrações séricas de ácidos graxos livres, neuropatia, encefalopatia e anormalidades no metabolismo do nitrogênio também são reportadas. | |||
| description / en | description / en | ||
Deficiency in humans is only described in long-term total parenteral nutrition patients receiving insufficient chromium. Hyperglycaemia or impaired glucose tolerance occurs. Elevated plasma free fatty acid concentrations, neuropathy, encephalopathy, and abnormalities in nitrogen metabolism are also reported. | |||
Revision as of 05:33, 13 August 2026
Deficiency in humans is only described in long-term total parenteral nutrition patients receiving insufficient chromium. Hyperglycaemia or impaired glucose tolerance occurs. Elevated plasma free fatty acid concentrations, neuropathy, encephalopathy, and abnormalities in nitrogen metabolism are also reported.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 5B5K.8 |
||
| English | Chromium deficiency |
Deficiency in humans is only described in long-term total parenteral nutrition patients receiving insufficient chromium. Hyperglycaemia or impaired glucose tolerance occurs. Elevated plasma free fatty acid concentrations, neuropathy, encephalopathy, and abnormalities in nitrogen metabolism are also reported. |
